Challenges coexist with opportunities: development of a macrocyclic peptide PET radioligand for PD-L1
European Journal of Nuclear Medicine and Molecular Imaging · 2024
DOI: 10.1007/s00259-024-06680-3 ↗Kurz gefasst
Editorial in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Wenpeng Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Peking University First Hospital, No.8 Xishiku Str, Xicheng District, Beijing, 100034, China. Hauptthemen laut MEDLINE: B7-H1 Antigen, Positron-Emission Tomography. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Peking University First Hospital, No.8 Xishiku Str, Xicheng District, Beijing, 100034, China.
- Department of Nuclear Medicine, Hospital 108, Hanoi, Vietnam.
- Department of Nuclear Medicine, Peking University First Hospital, No.8 Xishiku Str, Xicheng District, Beijing, 100034, China. kanglei@bjmu.edu.cn.
- Departments of Radiology and Medical Physics, University of Wisconsin - Madison, K6/562 Clinical Science Center, 600 Highland Ave, Madison, WI, 53705-2275, USA. wcai@uwhealth.org.
Förderung
- NCI NIH HHS
Zitieren
APA
Huang, W., Son, M. H., Ha, L. N., Kang, L., & Cai, W. (2024). Challenges coexist with opportunities: development of a macrocyclic peptide PET radioligand for PD-L1. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06680-3
Vancouver
Huang W, Son MH, Ha LN, Kang L, Cai W. Challenges coexist with opportunities: development of a macrocyclic peptide PET radioligand for PD-L1. European Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.1007/s00259-024-06680-3
BibTeX
@article{Huang2024,
author = {Huang, Wenpeng and Son, Mai Hong and Ha, Le Ngoc and Kang, Lei and Cai, Weibo},
title = {Challenges coexist with opportunities: development of a macrocyclic peptide PET radioligand for PD-L1},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2024},
doi = {10.1007/s00259-024-06680-3}
}
EUVIMED